Next-generation gene editing company to occupy three full floors of ground-up, Class A life sciences development in one of the top biotech markets in the U.S. SAN FRANCISCO – (January 26, 2022) – Savills announced that it completed an 85,165-square-foot lease relocation and expansion on behalf of Graphite Bio, Inc. (NASDAQ: GRPH) at 233 East Grand Avenue, a Class […]
Thank you for your interest in The Registry. If you'd like to read further, you must Subscribe or Log In below to read the rest of this content.
Signup for news and special announcements!
You have successfully joined our subscriber list.
The conditional deal, priced about $450,000 above the top of the city's...
ByThe RegistryOctober 6, 2026In an informational hearing on Oct. 1, the Planning Commission got a...
ByThe RegistryOctober 6, 2026SupplyBank.org has formally launched its roughly $200 million Oakport campus on utility-owned...
ByThe RegistryOctober 6, 2026The San Francisco Recovery Fund has formally brought BXP aboard as a...
ByThe RegistryOctober 6, 2026